Alentis Therapeutics Competitors and Similar CompaniesClear all
EyePoint Pharmaceuticals's competitors and similar companies include Sol-Gel Technologies and Faes Farma.
 EyePoint Pharmaceuticals EyePoint Pharmaceuticals (formerly pSivida) is a pharmaceutical company focused on the development of innovative miniaturized, sustained-release drug delivery products and technologies to treat serious, debilitating diseases of the eye that can lead to blindness. |  Sol-Gel Technologies Sol-Gel Technologies is engaged in the development of a range of specialty pharmaceuticals. |  Faes Farma Faes Farma is a pharmaceutical company that develops, produces and commercializes pharmaceutical products and raw materials. | |
Founding Date | Founding Date 1987 | Founding Date 1997 | Founding Date 1933 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Watertown, US HQ | Locations Ness Ziona, IL HQ | Locations Leioa, ES HQ Madrid, ES Atlanta, US |
Employees | Employees 8453% increase | Employees 34 | Employees 1,775 |
Valuation ($) | Valuation ($) 617.6 m | Valuation ($) 18 m | Valuation ($) 1.2 b |
Financial | |||
Revenue (est.) | Revenue (est.) $31.4m (FY, 2025) | Revenue (est.) $19.4m (FY, 2025) | Revenue (est.) €493.6m (FY, 2024) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods €167.1m (FY, 2024) |
Gross profit | Gross profit N/A | Gross profit $19.4m (FY, 2025) | Gross profit €342.9m (FY, 2024) |
Net income | Net income ($232m) (FY, 2025) | Net income ($6.1m) (FY, 2025) | Net income €111.1m (FY, 2024) |
For sources of this data, please see the company profile
View Company Profiles
Sol-Gel Technologies
HQ
Ness Ziona, IL
Employees
34
Sol-Gel Technologies is engaged in the development of a range of specialty pharmaceuticals.
View companyFaes Farma
HQ
Leioa, ES
Employees
1,775
Faes Farma is a pharmaceutical company that develops, produces and commercializes pharmaceutical products and raw materials.
View company